
    
      Double-blind, placebo controlled, prospective study in two groups of 20 patients. Control
      group (A) receives standard Epsilonaminocaproic acid treatment before cardiopulmonary bypass
      (10 gr loading dose, and 1 gr/hr infusion), and second group (B) receives placebo. Before
      start of Epsilonaminocaproic acid/placebo, D-Dimers and Thromboelastography are measured,
      repeated just before full heparinization. After heparinization group A receives placebo, and
      group B Epsilonaminocaproic acid.
    
  